Quantum Cyber N.V (QUCY) vs Exagen Inc. (XGN)

Quantum Cyber N.V and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $233.3M against $113.4M — 2.1× the size. Quantum Cyber N.V grew revenue faster over the last twelve months: 69.0% against 20.8%. Quantum Cyber N.V has the higher net margin (0.00% vs −26.6%) and the lower return on invested capital (−194.0% vs −68.3%). Across the 18 metrics below, Quantum Cyber N.V leads on 9 and Exagen Inc. on 9.

Valuation

Metric QUCY XGN Diagnostics & Research median
P/E n/m n/m 33.95
P/S 27.51 2.96 4.87
P/B 1.21 17.25 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 14.34 2.96 5.66
Earnings yield (877.41%) (9.29%) (1.75%)
Free cash flow yield (67.39%) (3.60%) (0.13%)

Profitability

Metric QUCY XGN Diagnostics & Research median
Gross margin 56.91% 58.64% 50.89%
Operating margin 0.00% (18.58%) (8.57%)
Net margin 0.00% (26.61%) (6.37%)
Free cash flow margin 0.00% (10.66%) 0.00%
Return on equity (325.19%) (113.82%) (2.92%)
Return on assets (224.96%) (34.19%) (6.71%)
Return on invested capital (193.99%) (68.33%) 0.00%

Growth

Metric QUCY XGN Diagnostics & Research median
Revenue growth (TTM) 68.99% 20.83% 7.69%
EPS growth (last fiscal year) 87.92% (12.05%) —
Revenue growth, 5-year CAGR 1.70% 9.66% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QUCY XGN Diagnostics & Research median
Debt to equity 0.00 2.00 0.11
Current ratio 5.56 3.18 2.02
Net debt to EBITDA (0.01) 0.68 0.78

Dividend

Metric QUCY XGN Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric QUCY XGN Diagnostics & Research median
Market cap 113.36m 233.29m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack